{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:58:49Z","timestamp":1794556729022,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2022AAC03398"],"award-info":[{"award-number":["2022AAC03398"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM201512043"],"award-info":[{"award-number":["SZSM201512043"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Diabetic osteoporosis (DOP) is one of the chronic complications of diabetes mellitus, but without a standardized treatment plan till now. Liuwei Dihuang pill (LDP) has gradually exerted a remarkable effect on DOP in recent years; its specific mechanism is not clear yet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We adopted network pharmacology approaches, including multi-database search, pharmacokinetic screening, network construction analysis, gene ontology enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and molecular docking to elaborate the active components, signaling pathways and potential mechanisms of LDP in the treatment of DOP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-seven active ingredients and 55 related disease targets have been found through integrated network pharmacology. Functional enrichment analysis shows that five key active ingredients, including beta-sitosterol, stigmasterol, diosgenin, tetrahydroalstonine, and kadsurenone, may give full scope to insulin secretion estrogen-level raising and angiogenesis in biological process through the pivotal targets. In addition, the underlying effect of PI3K\/AKT\/FOXO and VEGF pathways is also suggested in the treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Based on systematic network pharmacology methods, we predicted the basic pharmacological effects and potential mechanisms of LDP in the treatment of DOP, revealing that LDP may treat DOP through multiple targets and multiple signaling pathways, which provide evidence for the further study of pharmacological mechanism and broader clinical thinking.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13018-022-03194-2","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T09:03:43Z","timestamp":1655197423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhaoqi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"12","key":"3194_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726\u201333.","journal-title":"Osteoporos Int"},{"issue":"9","key":"3194_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/14712598.2019.1618266","volume":"19","author":"S Mohsin","year":"2019","unstructured":"Mohsin S, et al. An update on therapies for the treatment of diabetes-induced osteoporosis. Expert Opin Biol Ther. 2019;19(9):937\u201348.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"3194_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2018.01.095","volume":"496","author":"C Yao","year":"2018","unstructured":"Yao C, et al. Cereblon (CRBN) deletion reverses streptozotocin induced diabetic osteoporosis in mice. Biochem Biophys Res Commun. 2018;496(3):967\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"3194_CR4","first-page":"216","volume":"42","author":"ZB Gu Fulong","year":"2019","unstructured":"Gu Fulong ZB, Jiang J, Li Z. Clinical study on treatment of primary osteoporosis with deficiency of spleen and kidney by Bushen Jianpi Zhuanggu Prescription. J Chin Med Mater. 2019;42:216\u20138.","journal-title":"J Chin Med Mater"},{"key":"3194_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2019.101009","volume":"33","author":"P Feng","year":"2020","unstructured":"Feng P, Che Y, Chen D-Q. Molecular mechanism of action of Liuwei Dihuang pill for the treatment of osteoporosis based on network pharmacology and molecular docking. Eur J Integr Med. 2020;33: 101009.","journal-title":"Eur J Integr Med"},{"key":"3194_CR6","first-page":"53","volume":"38","author":"Z Yuhong","year":"2019","unstructured":"Yuhong Z. Liuwei Dihuang pills combined with sitagliptin in treating diabetic osteoporosis and its effects on glucolipid metabolism and osteocalcin. Inner Mong J Tradit Chin Med. 2019;38:53\u20134.","journal-title":"Inner Mong J Tradit Chin Med"},{"key":"3194_CR7","volume":"2013","author":"GB Zhang","year":"2013","unstructured":"Zhang GB, et al. Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med. 2013;2013: 621423.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3194_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"issue":"7","key":"3194_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040654","volume":"7","author":"SS Ahmed","year":"2012","unstructured":"Ahmed SS, Ramakrishnan V. Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS ONE. 2012;7(7): e40654.","journal-title":"PLoS ONE"},{"issue":"5","key":"3194_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/wcms.52","volume":"1","author":"O Ursu","year":"2011","unstructured":"Ursu O, et al. Understanding drug-likeness. WIREs Comput Mol Sci. 2011;1(5):760\u201381.","journal-title":"WIREs Comput Mol Sci"},{"key":"3194_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","volume":"46","author":"P Artursson","year":"2001","unstructured":"Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions qof drug transport. Adv Drug Deliv Rev. 2001;46:27\u201343.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3194_CR12","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","author":"T UniProt Consortium","year":"2018","unstructured":"UniProt Consortium T. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2018;46(5):2699.","journal-title":"Nucleic Acids Res"},{"key":"3194_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","volume":"13","author":"MCV Rebhan","year":"1997","unstructured":"Rebhan MCV, Prilusky J, Lancet D. GeneCards: kmegrat g information about genes, prote and diseases. Trends Genetics Tig. 1997;13:163.","journal-title":"Trends Genetics Tig"},{"key":"3194_CR14","doi-asserted-by":"publisher","first-page":"1.2.1","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger JS, Hamosh A. Searching Online Mendelian Inheritance in Man (OMIM): a knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinform. 2017;58:1.2.1-1.2.12.","journal-title":"Curr Protoc Bioinform"},{"issue":"Suppl 4","key":"3194_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"D1","key":"3194_CR16","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"3194_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GDBCW Hogue","year":"2003","unstructured":"Hogue GDBCW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2.","journal-title":"BMC Bioinform"},{"key":"3194_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fgene.2018.00469","volume":"9","author":"M Ni","year":"2018","unstructured":"Ni M, et al. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of non-small cell lung cancer via integrated bioinformatics analysis. Front Genet. 2018;9:469.","journal-title":"Front Genet"},{"issue":"2","key":"3194_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"11","key":"3194_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029087","volume":"101","author":"J Baek","year":"2022","unstructured":"Baek J, et al. The efficacy and safety of yukmijihwang-hwan (Liuweidihuang-wan) for type 2 diabetes mellitus without complications: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2022;101(11): e29087.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3194_CR21","first-page":"103","volume":"17","author":"XR Cheng","year":"2019","unstructured":"Cheng XR, et al. Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology. Chin J Nat Med. 2019;17(2):103\u201321.","journal-title":"Chin J Nat Med"},{"issue":"W1","key":"3194_CR22","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong G, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3194_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10(1):29.","journal-title":"J Cheminform"},{"issue":"6","key":"3194_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3109\/00498254.2011.644596","volume":"42","author":"Y Chen","year":"2012","unstructured":"Chen Y, et al. Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers. Xenobiotica. 2012;42(6):596\u2013602.","journal-title":"Xenobiotica"},{"issue":"1","key":"3194_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jep.2010.08.011","volume":"132","author":"Y Chen","year":"2010","unstructured":"Chen Y, et al. Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. J Ethnopharmacol. 2010;132(1):213\u20138.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3194_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11418-012-0641-3","volume":"67","author":"N Zhang","year":"2013","unstructured":"Zhang N, et al. Pharmacokinetics of the main compounds absorbed into blood after oral administration of Liu Wei Di Huang Wan, a typical combinatorial intervention of Chinese medical formula. J Nat Med. 2013;67(1):36\u201341.","journal-title":"J Nat Med"},{"issue":"9","key":"3194_CR27","doi-asserted-by":"publisher","first-page":"17130","DOI":"10.3390\/ijms150917130","volume":"15","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL\/OPG Ratio. Int J Mol Sci. 2014;15(9):17130\u201347.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3194_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jnutbio.2010.09.003","volume":"22","author":"EH Alcantara","year":"2011","unstructured":"Alcantara EH, et al. Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone-specific transcription factor Runx2 in osteoblastic MC3T3-E1 cells. J Nutr Biochem. 2011;22(11):1055\u201363.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"3194_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1124\/mol.104.010082","volume":"68","author":"ML Yen","year":"2005","unstructured":"Yen ML, et al. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase\/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol. 2005;68(4):1061\u201373.","journal-title":"Mol Pharmacol"},{"issue":"11","key":"3194_CR30","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/mnfr.200900609","volume":"54","author":"T Uemura","year":"2010","unstructured":"Uemura T, et al. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol Nutr Food Res. 2010;54(11):1596\u2013608.","journal-title":"Mol Nutr Food Res"},{"key":"3194_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jsbmb.2014.02.020","volume":"143","author":"K Sato","year":"2014","unstructured":"Sato K, Fujita S, Iemitsu M. Acute administration of diosgenin or dioscorea improves hyperglycemia with increases muscular steroidogenesis in STZ-induced type 1 diabetic rats. J Steroid Biochem Mol Biol. 2014;143:152\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3194_CR32","doi-asserted-by":"publisher","first-page":"7493694","DOI":"10.1155\/2016\/7493694","volume":"2016","author":"K Fang","year":"2016","unstructured":"Fang K, et al. Diosgenin and 5-methoxypsoralen ameliorate insulin resistance through ER-alpha\/PI3K\/Akt-signaling pathways in HepG2 cells. Evid Based Complement Alternat Med. 2016;2016:7493694.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3194_CR33","first-page":"700","volume":"14","author":"L Gan","year":"2008","unstructured":"Gan L, Chen Z, Jiang G, et al. Research of insulin, bone gla protein and parathyroid hormone in elderly diabetes mellitus with osteoporosis. Chin J Osteoporos. 2008;14:700\u20133.","journal-title":"Chin J Osteoporos"},{"key":"3194_CR34","first-page":"97","volume":"8","author":"LDML Jian-min","year":"2015","unstructured":"Jian-min LDML. Role of osteocalcin in glucose metabolism. Chin J Osteoporosis Bone Miner Res. 2015;8:97\u2013102.","journal-title":"Chin J Osteoporosis Bone Miner Res"},{"key":"3194_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fendo.2013.00021","volume":"4","author":"J Starup-Linde","year":"2013","unstructured":"Starup-Linde J. Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol (Lausanne). 2013;4:21.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3194_CR36","first-page":"455","volume":"28","author":"M Hie","year":"2011","unstructured":"Hie M, et al. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med. 2011;28(3):455\u201362.","journal-title":"Int J Mol Med"},{"issue":"2","key":"3194_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2015.02.091","volume":"461","author":"K Tanaka","year":"2015","unstructured":"Tanaka K, et al. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells. Biochem Biophys Res Commun. 2015;461(2):193\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"3194_CR38","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00198-014-2818-y","volume":"25","author":"HB Jia","year":"2014","unstructured":"Jia HB, et al. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats. Osteoporos Int. 2014;25(12):2743\u201354.","journal-title":"Osteoporos Int"},{"issue":"5","key":"3194_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1479164118779386","volume":"15","author":"N Zhong","year":"2018","unstructured":"Zhong N, et al. Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients. Diab Vasc Dis Res. 2018;15(5):433\u201341.","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"3194_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/03008207.2016.1171858","volume":"57","author":"J Peng","year":"2016","unstructured":"Peng J, et al. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice. Connect Tissue Res. 2016;57(4):277\u201389.","journal-title":"Connect Tissue Res"},{"issue":"3","key":"3194_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118823","volume":"10","author":"C Wallner","year":"2015","unstructured":"Wallner C, et al. Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration. PLoS ONE. 2015;10(3): e0118823.","journal-title":"PLoS ONE"},{"issue":"11","key":"3194_CR42","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, et al. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483\u201396.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"3194_CR43","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/jbm.a.34377","volume":"101","author":"YX Gu","year":"2013","unstructured":"Gu YX, et al. The roles of PI3K\/Akt signaling pathway in regulating MC3T3-E1 preosteoblast proliferation and differentiation on SLA and SLActive titanium surfaces. J Biomed Mater Res A. 2013;101(3):748\u201354.","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"3194_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10799893.2019.1625061","volume":"39","author":"JM Pan","year":"2019","unstructured":"Pan JM, et al. Dexamethasone suppresses osteogenesis of osteoblast via the PI3K\/Akt signaling pathway in vitro and in vivo. J Recept Signal Transduct Res. 2019;39(1):80\u20136.","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"3194_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yexcr.2017.09.018","volume":"360","author":"X Wu","year":"2017","unstructured":"Wu X, et al. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving beta-catenin. Exp Cell Res. 2017;360(2):281\u201391.","journal-title":"Exp Cell Res"},{"key":"3194_CR46","first-page":"7249","volume":"7","author":"L You","year":"2014","unstructured":"You L, Gu W, Chen L, Pan L, Chen J, Peng Y. MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K\/Akt signaling pathway. Int J Clin Exp Pathol. 2014;7:7249\u201361.","journal-title":"Int J Clin Exp Pathol"},{"key":"3194_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ejphar.2015.09.005","volume":"765","author":"X Ying","year":"2015","unstructured":"Ying X, et al. Silibinin alleviates high glucose-suppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3K\/Akt signaling. Eur J Pharmacol. 2015;765:394\u2013401.","journal-title":"Eur J Pharmacol"},{"key":"3194_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fendo.2019.00093","volume":"10","author":"C Sergi","year":"2019","unstructured":"Sergi C, Shen F, Liu SM. Insulin\/IGF-1R, SIRT1, and FOXOs Pathways-An Intriguing Interaction Platform for Bone and Osteosarcoma. Front Endocrinol (Lausanne). 2019;10:93.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"3194_CR49","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1172\/JCI68049","volume":"123","author":"S Iyer","year":"2013","unstructured":"Iyer S, et al. FOXOs attenuate bone formation by suppressing Wnt signaling. J Clin Invest. 2013;123(8):3409\u201319.","journal-title":"J Clin Invest"},{"key":"3194_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376.","journal-title":"Nat Med"},{"issue":"4","key":"3194_CR51","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1684\/ecn.2009.0170","volume":"20","author":"N Ferrara","year":"2009","unstructured":"Ferrara N. VEGF-A: a critical regulator of blood vessel growth. Eur Cytokine Netw. 2009;20(4):158\u201363.","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"3194_CR52","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1242\/dev.117952","volume":"142","author":"X Duan","year":"2015","unstructured":"Duan X, et al. Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. Development. 2015;142(11):1984\u201391.","journal-title":"Development"},{"issue":"3","key":"3194_CR53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","volume":"30","author":"A Oikawa","year":"2010","unstructured":"Oikawa A, et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol. 2010;30(3):498\u2013508.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"3194_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00395-010-0109-0","volume":"105","author":"A Orlandi","year":"2010","unstructured":"Orlandi A, et al. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol. 2010;105(6):703\u201312.","journal-title":"Basic Res Cardiol"},{"issue":"22","key":"3194_CR55","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","volume":"106","author":"OM Tepper","year":"2002","unstructured":"Tepper OM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781\u20136.","journal-title":"Circulation"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03194-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-022-03194-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-022-03194-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T03:35:15Z","timestamp":1700710515000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-022-03194-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3194"],"URL":"https:\/\/doi.org\/10.1186\/s13018-022-03194-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that there have no conflicts of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}